Raymond James & Associates’s First Trust Eurozone AlphaDEX FEUZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$536K Buy
12,267
+5,798
+90% +$248K ﹤0.01% 3069
2024
Q2
$268K Buy
+6,469
New +$278K ﹤0.01% 3438
2022
Q2
Sell
-8,728
Closed -$360K 4084
2022
Q1
$360K Sell
8,728
-4,334
-33% -$188K ﹤0.01% 3285
2021
Q4
$602K Buy
+13,062
New +$606K ﹤0.01% 2950
2019
Q1
Sell
-23,617
Closed -$807K 3651
2018
Q4
$807K Buy
23,617
+16,931
+253% +$625K ﹤0.01% 2216
2018
Q3
$279K Sell
6,686
-500
-7% -$21.3K ﹤0.01% 3084
2018
Q2
$300K Sell
7,186
-12,068
-63% -$540K ﹤0.01% 3024
2018
Q1
$865K Buy
19,254
+4,756
+33% +$216K ﹤0.01% 2236
2017
Q4
$636K Buy
14,498
+3,463
+31% +$149K ﹤0.01% 2396
2017
Q3
$469K Buy
+11,035
New +$452K ﹤0.01% 2525

Other funds holding FEUZ

Raymond James & Associates's FEUZ Position: Q3 2024 in Review

Raymond James & Associates increased its First Trust Eurozone AlphaDEX (FEUZ) stake by 90% in Q3 2024, buying an estimated $248K and bringing the position to 12,267 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #3069.

Raymond James & Associates first reported a position in FEUZ in Q3 2017 and has held it in 10 quarters since. The position peaked at $865K in Q1 2018. 22 funds tracked by Wall St. Rank hold FEUZ as of Q3 2024.

  • Raymond James & Associates held 12,267 shares of First Trust Eurozone AlphaDEX worth $536K as of Q3 2024.
  • Raymond James & Associates bought 5,798 First Trust Eurozone AlphaDEX shares in Q3 2024, an estimated $248K.
  • First Trust Eurozone AlphaDEX made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3069 holding.
  • Raymond James & Associates first reported a position in First Trust Eurozone AlphaDEX in Q3 2017 and has held it in 10 quarters since.
  • Raymond James & Associates's First Trust Eurozone AlphaDEX position peaked at $865K in Q1 2018.
  • 22 funds tracked by Wall St. Rank held First Trust Eurozone AlphaDEX as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.